ARRUGA, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 2.272
EU - Europa 1.685
AS - Asia 1.079
AF - Africa 44
SA - Sud America 26
OC - Oceania 13
Totale 5.119
Nazione #
US - Stati Uniti d'America 2.230
IT - Italia 710
CN - Cina 615
IE - Irlanda 180
SG - Singapore 176
SE - Svezia 153
DE - Germania 110
UA - Ucraina 99
FR - Francia 95
FI - Finlandia 59
GB - Regno Unito 56
JP - Giappone 54
KR - Corea 53
PL - Polonia 49
VN - Vietnam 35
CA - Canada 34
IN - India 34
ES - Italia 33
HK - Hong Kong 31
BE - Belgio 24
NL - Olanda 23
SN - Senegal 22
ID - Indonesia 17
AT - Austria 16
IR - Iran 16
EG - Egitto 14
CZ - Repubblica Ceca 13
TW - Taiwan 13
BR - Brasile 12
DK - Danimarca 12
AU - Australia 11
CH - Svizzera 11
RU - Federazione Russa 10
PH - Filippine 7
BY - Bielorussia 6
GR - Grecia 6
MO - Macao, regione amministrativa speciale della Cina 6
MX - Messico 6
RO - Romania 6
SA - Arabia Saudita 6
TR - Turchia 6
AR - Argentina 4
CO - Colombia 4
LU - Lussemburgo 4
UZ - Uzbekistan 4
EC - Ecuador 3
ZA - Sudafrica 3
ET - Etiopia 2
LT - Lituania 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
UY - Uruguay 2
BG - Bulgaria 1
CL - Cile 1
EE - Estonia 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 5.119
Città #
Chandler 344
Torino 203
Beijing 202
Dublin 178
Ann Arbor 138
Singapore 137
Fairfield 105
Ashburn 102
Houston 101
Nyköping 77
Turin 71
Medford 66
Wilmington 62
Santa Clara 60
Columbus 56
Guangzhou 52
Princeton 52
Redwood City 49
Woodbridge 48
Centro 45
Milan 45
Dearborn 44
Shanghai 43
Warsaw 43
Jacksonville 42
Villeurbanne 42
Fremont 35
New York 29
Cambridge 25
Hangzhou 24
Nanjing 24
Seattle 23
Pisa 22
Boston 21
Dong Ket 18
San Mateo 18
Tokyo 18
Jakarta 17
Brussels 16
Perugia 16
Vienna 14
Rome 13
Barcelona 12
Hefei 12
Munich 12
San Diego 12
Seoul 12
Wuhan 12
Garessio 11
Copenhagen 10
Norwalk 10
Xian 10
Brookline 9
Hebei 9
Kyoto 9
Boardman 8
Chicago 8
Helsinki 8
Vestignè 8
Des Moines 7
Falls Church 7
Shenyang 7
Toronto 7
Verona 7
Berlin 6
Bologna 6
Central 6
Chengdu 6
Dronten 6
Düsseldorf 6
Edmonton 6
Evanston 6
Hong Kong 6
Kunming 6
La Jolla 6
London 6
Los Angeles 6
Paris 6
Piemonte 6
Taipei 6
Tianjin 6
Ulm 6
Brescia 5
Changsha 5
Delhi 5
Genova 5
Philadelphia 5
Salvador 5
Washington 5
Wenzhou 5
Wroclaw 5
Ancona 4
Austin 4
Bogotá 4
Buffalo 4
Cairo 4
Capurso 4
Central District 4
Chaoyang 4
Chennai 4
Totale 3.136
Nome #
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 732
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications. 487
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22 322
Early prediction of treatment outcome in acute myeloid leukemia by measurment of WT1 transcript levels in peripheral blood samples collected after chemotherapy 184
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 161
Targeting metabolism and survival in chronic lymphocytic leukemia and richter syndrome cells by a novel NF-κB inhibitor 143
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation 141
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 126
The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies 117
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 111
Immune response dysfunction in chronic lymphocytic leukemia: Dissecting molecular mechanisms and microenvironmental conditions 106
USE OF CLINICAL EXOME SEQUENCING IN THE DIAGNOSTIC FLOW OF MONOGENIC KIDNEY DISEASES: THE PIEDMONT EXPERIENCE 106
NOVEL AND KNOWN MUTATIONS IDENTIFIED BY CLINICAL EXOME SEQUENCING FOR THE DIAGNOSIS OF POLYCYSTIC KIDNEY DISEASE 103
Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia 92
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient–derived xenograft mouse models 92
Chronic lymphocytic leukemia 87
The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance 86
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 84
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 79
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis. 77
Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22 76
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 76
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy 75
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia. 73
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes 72
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. 72
WT1 overexpression: A clinically useful marker in acute and chronic myeloid leukemias 71
HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study. 70
Deferasirox is a powerful NF-kappaB inhibitor inmyelodysplastic cells and in leukemia cell lines acting independently from celliron deprivation by chelation and reactive oxygen species scavenging 68
HaTSPiL: A modular pipeline for high throughput sequencing data analysis 67
NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line 65
Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets 64
Deferasiroxtreatment improved the hemoglobin level and decreased transfusion requirements infour patients with the myelodysplastic syndrome and primary myelofibrosis 62
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. 62
Identification of different Ikaros cDNAtranscripts in Philadelphia-positive adult acute lymphoblastic leukemia by ahigh-throughput capillary electrophoresis sizing method 60
Targeting the adenosinergic axis in chronic lymphocytic leukemia: A way to disrupt the tumor niche? 58
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia 57
Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models 57
A novel COLEC10 mutation in a child with 3MC syndrome 57
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leucemia cells 56
Myelodysplastic syndromes 54
Novel richter syndrome xenograft models to study genetic architecture, biology, and therapy responses 54
Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients 54
Expression of the Tigit/CD226/CD155 Receptors/Ligand System in Chronic Lymphocytic Leukemia 52
NOTCH1 Stabilization By PEST Mutations Enhances IgM-Mediated Activity in Chronic Lymphocytic Leukemia 51
Validation of a Simple, Rapid, and Cost-Effective Method for Acute Rejection Monitoring in Lung Transplant Recipients 50
Expression of spliced oncogenic Ikaros isoforms inPhiladelphia-positive acute lymphoblastic leukemia patients treated with tyrosinekinase inhibitors: implications for a new mechanism of resistance 50
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients 47
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation 43
Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia 42
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia 22
Totale 5.273
Categoria #
all - tutte 15.998
article - articoli 0
book - libri 0
conference - conferenze 1.775
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020344 0 0 0 0 28 77 53 36 28 60 42 20
2020/2021783 36 45 40 19 137 41 91 58 117 67 40 92
2021/20221.025 71 42 74 74 74 129 70 46 44 102 167 132
2022/20231.134 126 114 26 94 89 240 80 88 128 41 61 47
2023/2024718 81 97 42 31 74 87 22 57 24 59 57 87
2024/2025485 47 74 63 159 142 0 0 0 0 0 0 0
Totale 5.273